An Outbreak of Crimean-Congo hemorrhagic fever (CCHF) in South Africa in 2022
DOI:
https://doi.org/10.31646/gbio.203Abstract
Crimean-Congo Hemorrhagic Fever (CCHF) is a vector-borne disease caused by a tick-borne virus (Nairovirus) of the Bunyaviridae family. The onset of CCHF is sudden, with initial signs and symptoms including headache, high fever, back pain, joint pain, stomach pain, and vomiting. As the illness progresses, large areas of severe bruising, and bleeds can be seen, with case fatality as high as nine to 50%. This watching brief describes the Outbreak of CCHF in South Africa in 2022. There are 2 reported cases of CCHF in South Africa, in September 2022 with the case fatality rate (CFR) of 50%. Second case was laboratory confirmed on 10th September 2022. Although there are currently only two CCHF cases reported in South Africa, the unknown source is of concern and should be considered a warning signal for increased numbers in the future. For prevention, individuals must avoid contact with the blood and body fluids of livestock or humans who show symptoms of infection. Agricultural workers and others working with animals should use insect repellent containing DEET (N, N-diethyl-m- toluamide) on exposed skin and clothing for preventing tick bites. It is important for healthcare workers to use proper infection control precautions to prevent occupational exposure. There is no safe and effective vaccine currently available for human use. Treatment for CCHF is primarily supportive, and appropriate treatment of secondary infections.Published
2023-06-19
How to Cite
Betodkar, U., Khiangte, Z., & Vanlalrengpuia. (2023). An Outbreak of Crimean-Congo hemorrhagic fever (CCHF) in South Africa in 2022. Global Biosecurity, 5(1). https://doi.org/10.31646/gbio.203
Issue
Section
Watching Briefs
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2023-02-27
Accepted 2023-04-26
Published 2023-06-19
Accepted 2023-04-26
Published 2023-06-19